Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
894 results
894
Total Filings
$6934.4B
Total Raised
69
424B4 Offerings
254
ATM Programs
126
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 | ATRA | Healthcare | Biotechnology | $72M | ATM | — | $8.04 | — | — | — | Cowen | Atara Biotherapeutics selling $79.3 million in common stock through TD Securities at-the-market offering; proceeds for general corporate purposes. |
| May 12 | ICCM | Healthcare | Medical - Devices | $8M | ATM | — | $3.60 | — | — | — | — | ICeCure Medical (ICCM) is selling up to $4,339,697 of ordinary shares at-the-market through A.G.P./Alliance Global Partners, with proceeds for general corporate purposes. |
| May 11 | JEF | Financial Services | Financial - Capital Markets | $11.0B | ATM |
$52.98
floor
|
$53.96 | +1.8% | — | — | Jefferies | Jefferies Financial Group Inc. may sell up to 25 million common shares at market prices through Jefferies LLC as sales agent; proceeds use unspecified, up to 3.0% commission applies. |
| May 11 | VVX | Industrials | Aerospace & Defense | $2.3B | Public Offering |
$73.91
floor
|
$74.64 | +1.0% | — | — | Morgan Stanley | A selling shareholder is offering 2,004,569 shares of V2X, Inc. common stock at $74.35 per share, raising $149.0 million in gross proceeds, with V2X receiving none of the proceeds. |
| May 11 | AVBP | Healthcare | Biotechnology | $1.5B | ATM |
$29.50
floor
|
$32.54 | +10.3% | — | — | Jefferies | Avibro Pharmaceuticals (AVBP) is raising up to $250 million through an at-the-market offering of common stock at prevailing market prices via Jefferies as sales agent; proceeds will be used for general corporate purposes. |
| May 11 | NVTS | Technology | Semiconductors | $3.2B | ATM | — | $13.09 | — | — | — | UBS, Jefferies | Navitas Semiconductor Corporation offering up to $125 million Class A common stock at-the-market through Craig-Hallum Capital Group and UBS Securities; proceeds for general corporate purposes. |
| May 11 | INSW | Energy | Oil & Gas Midstream | $4.4B | Public Offering |
$91.62
floor
|
$88.12 | -3.8% | — | — | B. Riley | International Seaways, Inc. is selling up to $200 million of common shares at-the-market through four sales agents; proceeds will be used for general corporate purposes. |
| May 11 | MAC | Real Estate | REIT - Retail | $7.4B | Public Offering |
$19.99
floor
|
$24.89 | +24.5% | — | — | Goldman Sachs, J.P. Morgan, Deutsche Bank | Macy's (MAC) is issuing 16 million common shares via Goldman Sachs; pricing and proceeds use not specified in this preliminary prospectus supplement dated May 11, 2026. |
| May 8 | NKTR | Healthcare | Biotechnology | $1.3B | Public Offering |
$85.09
floor
|
$67.17 | -21.1% | — | — | — | Nektar Therapeutics selling up to $150 million in common stock at-the-market through Guggenheim Securities and H.C. Wainwright; proceeds for general corporate purposes. |
| May 8 | O | Real Estate | REIT - Retail | $59.5B | ATM | — | $63.77 | — | — | — | Barclays, BofA, Citigroup, Deutsche Bank, Goldman Sachs, Jefferies | Realty Income Corporation (O) is selling up to 150 million common shares at market prices through multiple agents under a sales agreement dated May 7, 2026, with proceeds for general corporate purposes. |
| May 8 | VRDN | Healthcare | Biotechnology | $1.7B | Secondary | — | $19.08 | — | 7.4M | — | Jefferies | Viridian Therapeutics (VRDN) is offering 7,352,942 shares of common stock at $17.00 per share to raise approximately $125 million, with net proceeds of $117.5 million before expenses. |
| May 8 | LTRX | Technology | Communication Equipment | $239M | ATM | — | $5.36 | — | — | — | Needham | Lantronix is selling up to $30 million in common stock at-the-market through Needham & Company and Canaccord Genuity, with proceeds for general corporate purposes. |
| May 8 | UBXG | Technology | Software - Infrastructure | $4M | Public Offering |
$0.30
floor
|
$4.61 | +1436.7% | — | — | — | U-BX Technology Ltd. is offering 15,166,668 units (each containing one Class A Ordinary Share and one warrant) on a best-efforts basis; filing does not specify offering price or use of proceeds. |
| May 8 | PHVS | Healthcare | Biotechnology | $2.4B | Public Offering | — | $34.42 | — | — | — | — | Pharvaris N.V. is offering 3,874,664 ordinary shares at $29.68 per share, raising approximately $115 million in gross proceeds for general corporate purposes. |
| May 8 | SVCO | Technology | Software - Application | $335M | ATM |
$12.46
floor
|
$10.22 | -18.0% | 753K | $9M | Jefferies | Silvaco Group, Inc. is raising up to $35 million through an at-the-market offering of common stock via Jefferies LLC, with proceeds for general corporate purposes. |
| May 8 | ED | Utilities | Regulated Electric | $41.3B | Public Offering |
$106.39
floor
|
$111.96 | +5.2% | — | — | Barclays, BofA, Jefferies, J.P. Morgan, KeyBanc, Wells Fargo | Consolidated Edison is raising up to $2 billion through an equity distribution agreement with ten sales agents to sell common shares at market prices over time for general corporate purposes. |
| May 8 | SDSTW | — | — | — | ATM | — | — | — | 10.4M | — | B. Riley | Stardust Power Inc. is selling up to $5 million of common stock at market prices through B. Riley Securities; proceeds will be used for general corporate purposes. |
| May 8 | HOVRW | — | — | — | Public Offering |
$2.81
floor
|
— | — | — | — | — | New Horizon Aircraft Ltd. is selling 9,254,889 Class A ordinary shares at $2.81 per share in a registered direct offering, raising approximately $26.0 million, with proceeds for general corporate purposes. |
| May 8 | ARTV | Healthcare | Biotechnology | $231M | Public Offering | — | $9.35 | — | 23.9M | — | Jefferies, Cowen, Needham | ARTV sells 23.9M common shares and 2.2M pre-funded warrants at $11.52/share, raising ~$300M gross proceeds for general corporate purposes. |
| May 8 | OUST | Technology | Hardware, Equipment & Parts | $2.7B | ATM | — | $41.97 | — | — | — | Oppenheimer | Ouster, Inc. is selling up to $100 million in common stock at-the-market through four agents, with proceeds for general corporate purposes and no specified use mentioned. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →